SCHEMBL417495

SCHEMBL417495

C[N+]1(CCCCCC[N+]2(C)CCCCC2)CCCCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.57
APOBEC3A P31941 2/20 0.57
APOBEC3G Q9HC16 2/20 0.57
KMT2A Q03164 2/20 0.57
BBOX1 O75936 2/20 0.54
KDM4E B2RXH2 1/20 0.52
CYP3A4 P08684 1/20 0.52
TSHR P16473 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
CTDSP1 Q9GZU7 1/20 0.46
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
TP53 P04637 1/20 0.39
GNAI3 P08754 1/20 0.38
GNAO1 P09471 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3037609 1.00 LMNA (0.57) LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1
SCHEMBL12638422 1.00 LMNA (0.57) LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1
SCHEMBL3043744 1.00 LMNA (0.57) LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1
SCHEMBL923466 1.00 LMNA (0.57) LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1
SCHEMBL3040478 1.00 LMNA (0.57) LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1
Water SCHEMBL23525630 0.97 LMNA (0.55) LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1
Hydrochloric Acid SCHEMBL29716086 0.97 BBOX1 (0.56) LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1
Water SCHEMBL14914647 0.97 LMNA (0.55) LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1
Bromide SCHEMBL14914316 0.97 LMNA (0.55) LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1
Water SCHEMBL14861565 0.97 LMNA (0.55) LMNAAPOBEC3AAPOBEC3GKMT2ABBOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024120972-A1 CATALYST COMPRISING AN AFX-STRUCTURE IZM-9 ZEOLITE OF VERY HIGH PURITY, AND AT LEAST ONE TRANSITION METAL FOR SELECTIVE REDUCTION OF NOX IFP Energies Nouvelles (FR) 2024-06-13 WO claimed
EP-3801892-B1 METHOD FOR PREPARING A HIGH-PURITY AFX STRUCTURAL ZEOLITE WITH A NITROGEN-CONTAINING ORGANIC STRUCTURING AGENT IFP ENERGIES NOW (FR) 2024-04-17 EP claimed
EP-4340993-A1 SYNTHESIS OF A PALLADIUM-BEARING AFX ZEOLITE CATALYST FOR NOX ADSORPTION IFP Energies nouvelles (FR) 2024-03-27 EP claimed
EP-4340992-A1 SYNTHESIS OF A COMPOSITE AFX-BEA ZEOLITE CATALYST CONTAINING PALLADIUM FOR NOX ADSORPTION IFP Energies nouvelles (FR) 2024-03-27 EP claimed
EP-4037828-B1 LOW-TEMPERATURE SYNTHESIS OF HIGH-PURITY AFX ZEOLITE IFP ENERGIES NOW (FR) 2023-11-08 EP claimed
EP-3801894-B1 CATALYST COMPRISING A MIXTURE OF AN AFX-STRUCTURE ZEOLITE AND A BEA-STRUCTURE ZEOLITE AND AT LEAST ONE TRANSITION METAL FOR SELECTIVE REDUCTION OF NOX IFP ENERGIES NOW (FR) 2023-08-09 EP claimed
EP-3801895-B1 METHOD FOR SYNTHESIZING A COMPOSITE MATERIAL CONSISTING OF A MIXTURE OF AFX- AND BEA-STRUCTURE ZEOLITES IN THE PRESENCE OF AN ORGANIC NITROGEN-CONTAINING STRUCTURING AGENT IFP ENERGIES NOW (FR) 2023-05-03 EP claimed
WO-2022243164-A1 SYNTHESIS OF A PALLADIUM-BEARING AFX ZEOLITE CATALYST FOR NOX ADSORPTION IFP Energies Nouvelles (FR) 2022-11-24 WO claimed
EP-4037830-A1 LOW-TEMPERATURE SYNTHESIS OF CATALYST BASED ON ZEOLITE AFX AND APPLICATION THEREOF IN NH3-SCR IFP Energies nouvelles (FR) 2022-08-10 EP claimed
CN-108495816-B High charge density metalloaluminophosphate molecular sieves 环球油品公司 2022-05-03 CN claimed
EP-2766303-B1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RES & ENG CO (US) 2017-11-22 EP claimed
EP-3188827-A1 EMM-26, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION, AND ITS USE Exxonmobil Research And Engineering Company (US) 2017-07-12 EP claimed
US-20160102590-A1 METHODS OF MAKING POROUS CRYSTALLINE MATERIALS AND THEIR USE IN HYDROCARBON SORPTION EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-04-14 US claimed
WO-2016036590-A1 EMM-26, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION, AND ITS USE EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-03-10 WO claimed
US-20160060129-A1 EMM-26, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION, AND ITS USE EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-03-03 US claimed
US-8916130-B2 Synthesis of MSE-framework type molecular sieves EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2014-12-23 US claimed
US-20130115163-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-05-09 US claimed
US-8361435-B2 IZM-2 crystalline solid and process for its preparation IFP Energies Nouvelles (FR) 2013-01-29 US claimed
EP-2170769-B1 CRYSTALLINE SOLID IZM-2 AND METHOD FOR THE PREPARATION THEREOF IFP Energies Nouvelles (FR) 2011-03-30 EP claimed
US-20100272624-A1 IZM-2 CRYSTALLINE SOLID AND PROCESS FOR ITS PREPARATION IFP (FR) 2010-10-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130115163-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES MRPS2, UFM1, B2M LMNA 3760/4885APOBEC3A 4483/4885APOBEC3G 4175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.